nodes	percent_of_prediction	percent_of_DWPC	metapath
Molindone—Immobile—Medroxyprogesterone Acetate—uterine cancer	0.2	0.207	CcSEcCtD
Molindone—Throat tightness—Progesterone—uterine cancer	0.0424	0.044	CcSEcCtD
Molindone—Galactorrhoea—Progesterone—uterine cancer	0.0321	0.0332	CcSEcCtD
Molindone—Pigmentation disorder—Etoposide—uterine cancer	0.0319	0.033	CcSEcCtD
Molindone—Libido increased—Medroxyprogesterone Acetate—uterine cancer	0.031	0.0321	CcSEcCtD
Molindone—Galactorrhoea—Medroxyprogesterone Acetate—uterine cancer	0.0291	0.0301	CcSEcCtD
Molindone—Amenorrhoea—Progesterone—uterine cancer	0.0237	0.0245	CcSEcCtD
Molindone—Throat tightness—Etoposide—uterine cancer	0.0217	0.0225	CcSEcCtD
Molindone—Amenorrhoea—Medroxyprogesterone Acetate—uterine cancer	0.0215	0.0222	CcSEcCtD
Molindone—Leukocytosis—Medroxyprogesterone Acetate—uterine cancer	0.0201	0.0208	CcSEcCtD
Molindone—Pigmentation disorder—Epirubicin—uterine cancer	0.0179	0.0185	CcSEcCtD
Molindone—Pigmentation disorder—Doxorubicin—uterine cancer	0.0165	0.0171	CcSEcCtD
Molindone—Euphoric mood—Medroxyprogesterone Acetate—uterine cancer	0.0162	0.0168	CcSEcCtD
Molindone—Disturbance in sexual arousal—Progesterone—uterine cancer	0.015	0.0155	CcSEcCtD
Molindone—Disturbance in sexual arousal—Medroxyprogesterone Acetate—uterine cancer	0.0136	0.0141	CcSEcCtD
Molindone—Dysphagia—Progesterone—uterine cancer	0.0131	0.0135	CcSEcCtD
Molindone—Urinary retention—Medroxyprogesterone Acetate—uterine cancer	0.013	0.0135	CcSEcCtD
Molindone—Weight increased—Progesterone—uterine cancer	0.0119	0.0123	CcSEcCtD
Molindone—Dysphagia—Medroxyprogesterone Acetate—uterine cancer	0.0118	0.0123	CcSEcCtD
Molindone—Weight decreased—Progesterone—uterine cancer	0.0118	0.0122	CcSEcCtD
Molindone—Drowsiness—Progesterone—uterine cancer	0.0116	0.0121	CcSEcCtD
Molindone—Weight increased—Medroxyprogesterone Acetate—uterine cancer	0.0108	0.0112	CcSEcCtD
Molindone—Weight decreased—Medroxyprogesterone Acetate—uterine cancer	0.0107	0.0111	CcSEcCtD
Molindone—Drowsiness—Medroxyprogesterone Acetate—uterine cancer	0.0106	0.0109	CcSEcCtD
Molindone—Dysphagia—Dactinomycin—uterine cancer	0.00923	0.00956	CcSEcCtD
Molindone—Muscle spasms—Progesterone—uterine cancer	0.00875	0.00906	CcSEcCtD
Molindone—Vision blurred—Progesterone—uterine cancer	0.00858	0.00888	CcSEcCtD
Molindone—Tremor—Progesterone—uterine cancer	0.00852	0.00883	CcSEcCtD
Molindone—Muscle spasms—Medroxyprogesterone Acetate—uterine cancer	0.00793	0.00821	CcSEcCtD
Molindone—Tremor—Medroxyprogesterone Acetate—uterine cancer	0.00772	0.008	CcSEcCtD
Molindone—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.00758	0.00785	CcSEcCtD
Molindone—Dry mouth—Progesterone—uterine cancer	0.00758	0.00785	CcSEcCtD
Molindone—Tachycardia—Progesterone—uterine cancer	0.00725	0.00751	CcSEcCtD
Molindone—Hypotension—Progesterone—uterine cancer	0.00694	0.00719	CcSEcCtD
Molindone—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.00686	0.00711	CcSEcCtD
Molindone—Amenorrhoea—Epirubicin—uterine cancer	0.00679	0.00704	CcSEcCtD
Molindone—Dysphagia—Etoposide—uterine cancer	0.00668	0.00692	CcSEcCtD
Molindone—Dyspnoea—Progesterone—uterine cancer	0.00662	0.00686	CcSEcCtD
Molindone—Somnolence—Progesterone—uterine cancer	0.0066	0.00684	CcSEcCtD
Molindone—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.00657	0.0068	CcSEcCtD
Molindone—Dyskinesia—Epirubicin—uterine cancer	0.00635	0.00658	CcSEcCtD
Molindone—Constipation—Progesterone—uterine cancer	0.00635	0.00658	CcSEcCtD
Molindone—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00629	0.00651	CcSEcCtD
Molindone—Amenorrhoea—Doxorubicin—uterine cancer	0.00629	0.00651	CcSEcCtD
Molindone—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.006	0.00621	CcSEcCtD
Molindone—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00598	0.0062	CcSEcCtD
Molindone—Dyskinesia—Doxorubicin—uterine cancer	0.00588	0.00609	CcSEcCtD
Molindone—Salivary hypersecretion—Epirubicin—uterine cancer	0.0058	0.006	CcSEcCtD
Molindone—Leukopenia—Dactinomycin—uterine cancer	0.00576	0.00596	CcSEcCtD
Molindone—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00575	0.00596	CcSEcCtD
Molindone—Salivary hypersecretion—Doxorubicin—uterine cancer	0.00536	0.00556	CcSEcCtD
Molindone—HTR7—artery—uterine cancer	0.00492	0.142	CbGeAlD
Molindone—Rash—Progesterone—uterine cancer	0.00468	0.00485	CcSEcCtD
Molindone—Dermatitis—Progesterone—uterine cancer	0.00468	0.00485	CcSEcCtD
Molindone—Muscle spasms—Etoposide—uterine cancer	0.00448	0.00464	CcSEcCtD
Molindone—Nausea—Progesterone—uterine cancer	0.00441	0.00457	CcSEcCtD
Molindone—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00424	0.00439	CcSEcCtD
Molindone—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00424	0.00439	CcSEcCtD
Molindone—Leukopenia—Etoposide—uterine cancer	0.00417	0.00432	CcSEcCtD
Molindone—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.004	0.00414	CcSEcCtD
Molindone—Dysphagia—Epirubicin—uterine cancer	0.00374	0.00388	CcSEcCtD
Molindone—Tachycardia—Etoposide—uterine cancer	0.00371	0.00384	CcSEcCtD
Molindone—Hypotension—Etoposide—uterine cancer	0.00355	0.00368	CcSEcCtD
Molindone—Dysphagia—Doxorubicin—uterine cancer	0.00346	0.00359	CcSEcCtD
Molindone—Weight increased—Epirubicin—uterine cancer	0.00341	0.00353	CcSEcCtD
Molindone—Weight decreased—Epirubicin—uterine cancer	0.00339	0.00351	CcSEcCtD
Molindone—Dyspnoea—Etoposide—uterine cancer	0.00339	0.00351	CcSEcCtD
Molindone—Somnolence—Etoposide—uterine cancer	0.00338	0.0035	CcSEcCtD
Molindone—Drowsiness—Epirubicin—uterine cancer	0.00334	0.00346	CcSEcCtD
Molindone—Rash—Dactinomycin—uterine cancer	0.00331	0.00343	CcSEcCtD
Molindone—Constipation—Etoposide—uterine cancer	0.00325	0.00336	CcSEcCtD
Molindone—Weight increased—Doxorubicin—uterine cancer	0.00315	0.00327	CcSEcCtD
Molindone—Weight decreased—Doxorubicin—uterine cancer	0.00313	0.00325	CcSEcCtD
Molindone—Nausea—Dactinomycin—uterine cancer	0.00312	0.00323	CcSEcCtD
Molindone—Drowsiness—Doxorubicin—uterine cancer	0.00309	0.0032	CcSEcCtD
Molindone—HTR2A—artery—uterine cancer	0.00307	0.0887	CbGeAlD
Molindone—Muscle spasms—Epirubicin—uterine cancer	0.00251	0.0026	CcSEcCtD
Molindone—Vision blurred—Epirubicin—uterine cancer	0.00246	0.00255	CcSEcCtD
Molindone—Agitation—Epirubicin—uterine cancer	0.0024	0.00248	CcSEcCtD
Molindone—Rash—Etoposide—uterine cancer	0.0024	0.00248	CcSEcCtD
Molindone—Dermatitis—Etoposide—uterine cancer	0.00239	0.00248	CcSEcCtD
Molindone—Leukopenia—Epirubicin—uterine cancer	0.00234	0.00242	CcSEcCtD
Molindone—Muscle spasms—Doxorubicin—uterine cancer	0.00232	0.0024	CcSEcCtD
Molindone—Vision blurred—Doxorubicin—uterine cancer	0.00228	0.00236	CcSEcCtD
Molindone—Nausea—Etoposide—uterine cancer	0.00226	0.00234	CcSEcCtD
Molindone—Agitation—Doxorubicin—uterine cancer	0.00222	0.0023	CcSEcCtD
Molindone—Dry mouth—Epirubicin—uterine cancer	0.00217	0.00225	CcSEcCtD
Molindone—Leukopenia—Doxorubicin—uterine cancer	0.00216	0.00224	CcSEcCtD
Molindone—Tachycardia—Epirubicin—uterine cancer	0.00208	0.00215	CcSEcCtD
Molindone—Dry mouth—Doxorubicin—uterine cancer	0.00201	0.00208	CcSEcCtD
Molindone—Hypotension—Epirubicin—uterine cancer	0.00199	0.00206	CcSEcCtD
Molindone—Tachycardia—Doxorubicin—uterine cancer	0.00192	0.00199	CcSEcCtD
Molindone—Dyspnoea—Epirubicin—uterine cancer	0.0019	0.00197	CcSEcCtD
Molindone—Somnolence—Epirubicin—uterine cancer	0.00189	0.00196	CcSEcCtD
Molindone—HTR7—epithelium—uterine cancer	0.00187	0.0539	CbGeAlD
Molindone—Hypotension—Doxorubicin—uterine cancer	0.00184	0.00191	CcSEcCtD
Molindone—Constipation—Epirubicin—uterine cancer	0.00182	0.00189	CcSEcCtD
Molindone—HTR1A—renal system—uterine cancer	0.00181	0.0523	CbGeAlD
Molindone—HTR7—smooth muscle tissue—uterine cancer	0.0018	0.0519	CbGeAlD
Molindone—Dyspnoea—Doxorubicin—uterine cancer	0.00176	0.00182	CcSEcCtD
Molindone—Somnolence—Doxorubicin—uterine cancer	0.00175	0.00181	CcSEcCtD
Molindone—ADRA2A—myometrium—uterine cancer	0.00174	0.0504	CbGeAlD
Molindone—HTR7—renal system—uterine cancer	0.00173	0.05	CbGeAlD
Molindone—Constipation—Doxorubicin—uterine cancer	0.00168	0.00175	CcSEcCtD
Molindone—CHRM1—female reproductive system—uterine cancer	0.00163	0.047	CbGeAlD
Molindone—HTR7—female reproductive system—uterine cancer	0.00139	0.04	CbGeAlD
Molindone—ADRA2A—uterine cervix—uterine cancer	0.00136	0.0392	CbGeAlD
Molindone—Rash—Epirubicin—uterine cancer	0.00134	0.00139	CcSEcCtD
Molindone—Dermatitis—Epirubicin—uterine cancer	0.00134	0.00139	CcSEcCtD
Molindone—ADRA2A—decidua—uterine cancer	0.00129	0.0373	CbGeAlD
Molindone—Nausea—Epirubicin—uterine cancer	0.00126	0.00131	CcSEcCtD
Molindone—Rash—Doxorubicin—uterine cancer	0.00124	0.00129	CcSEcCtD
Molindone—Dermatitis—Doxorubicin—uterine cancer	0.00124	0.00129	CcSEcCtD
Molindone—ADRA2A—endometrium—uterine cancer	0.00123	0.0355	CbGeAlD
Molindone—ADRA2A—mammalian vulva—uterine cancer	0.00119	0.0343	CbGeAlD
Molindone—Nausea—Doxorubicin—uterine cancer	0.00117	0.00121	CcSEcCtD
Molindone—HTR2A—epithelium—uterine cancer	0.00116	0.0336	CbGeAlD
Molindone—ADRA2A—uterus—uterine cancer	0.00113	0.0327	CbGeAlD
Molindone—HTR2A—smooth muscle tissue—uterine cancer	0.00112	0.0324	CbGeAlD
Molindone—HTR2A—renal system—uterine cancer	0.00108	0.0312	CbGeAlD
Molindone—ADRA2A—female reproductive system—uterine cancer	0.00102	0.0294	CbGeAlD
Molindone—ADRA2A—female gonad—uterine cancer	0.000925	0.0267	CbGeAlD
Molindone—ADRA2A—vagina—uterine cancer	0.000919	0.0266	CbGeAlD
Molindone—HTR2A—female reproductive system—uterine cancer	0.000864	0.025	CbGeAlD
Molindone—HTR2A—vagina—uterine cancer	0.000781	0.0226	CbGeAlD
Molindone—ADRA2A—lymph node—uterine cancer	0.000594	0.0172	CbGeAlD
